Related references
Note: Only part of the references are listed.Association between CT-based body composition assessment and patient outcomes during neoadjuvant chemotherapy for epithelial ovarian cancer
Nicole Wood et al.
GYNECOLOGIC ONCOLOGY (2023)
GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia
Ja Young Kim-Muller et al.
CELL REPORTS (2023)
Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis
Yue Jin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)
Cancer cachexia: molecular mechanisms and treatment strategies
Tania Setiawan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)
Body Composition and Metabolic Dysfunction Really Matter for the Achievement of Better Outcomes in High-Grade Serous Ovarian Cancer
Mauricio A. Cuello et al.
CANCERS (2023)
Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer
Wen-Han Hsu et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)
Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced-stage ovarian cancer
Chia-Sui Weng et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2023)
Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis
E. H. Sutton et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2022)
RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice
Fabrizio Pin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2022)
Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study
Yi Luan et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
Ovarian cancer ascites induces skeletal muscle wasting in vitro and reflects sarcopenia in patients
Jorne Ubachs et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
Water-soluble dietary fiber alleviates cancer-induced muscle wasting through changes in gut microenvironment in mice
Tomoki Sakakida et al.
CANCER SCIENCE (2022)
Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis
Anastasios Tranoulis et al.
EJSO (2022)
Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin
Xiaoling Zhong et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)
Cancer cachexia impact on chemotherapy dose reduction, treatment discontinuation, and survival: A qualitative systematic review.
Philip D. Bonomi et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Browning of the white adipose tissue regulation: new insights into nutritional and metabolic relevance in health and diseases
Sabrina Azevedo Machado et al.
NUTRITION & METABOLISM (2022)
Body composition as a predictor of chemotherapy-related toxicity in ovarian cancer patients: A systematic review
Stefania Rizzo et al.
FRONTIERS IN ONCOLOGY (2022)
Bone loss induced by cancer treatments in breast and prostate cancer patients
Santos Castaneda et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2022)
Understanding the molecular basis of anorexia and tissue wasting in cancer cachexia
Eunbyul Yeom et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2022)
Patients triaged to neoadjuvant chemotherapy have higher rates of sarcopenia: An opportunity for prehabilitation
P. P. Fadadu et al.
GYNECOLOGIC ONCOLOGY (2021)
Psoas muscle index at the fifth lumbar vertebra as a predictor of survival in epithelial ovarian cancers
Tomoyuki Yoshikawa et al.
MOLECULAR AND CLINICAL ONCOLOGY (2021)
Association of body composition with toxicity to first-line chemotherapy and three-year survival in women with ovarian adenocarcinoma
Karine de Aguiar Bruno et al.
ACTA ONCOLOGICA (2021)
Non-bone metastatic cancers promote osteocyte-induced bone destruction
Fabrizio Pin et al.
CANCER LETTERS (2021)
The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
Hidetaka Wakabayashi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
Role of autophagy in muscle disease
Anais Franco-Romero et al.
MOLECULAR ASPECTS OF MEDICINE (2021)
MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer
Joshua R. Huot et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
Ami Patel et al.
CANCERS (2021)
Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass
Alex R. Straughn et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Pancreatic cancer cachexia: three dimensions of a complex syndrome
Maximilian Kordes et al.
BRITISH JOURNAL OF CANCER (2021)
Loss of REDD1 prevents chemotherapy-induced muscle atrophy and weakness in mice
Brian A. Hain et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
Role of myokines and osteokines in cancer cachexia
Fabrizio Pin et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2021)
Computed Tomography-Based Body Composition in Patients With Ovarian Cancer: Association With Chemotoxicity and Prognosis
Maria Del Grande et al.
FRONTIERS IN ONCOLOGY (2021)
Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia
Joseph E. Rupert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Regulation of Myostatin on the Growth and Development of Skeletal Muscle
Ming-Ming Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Can conditions of skeletal muscle loss be improved by combining exercise with anabolic-androgenic steroids? A systematic review and meta-analysis of testosterone-based interventions
Hugo Falqueto et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2021)
The Effects of Pro-, Pre-, and Synbiotics on Muscle Wasting, a Systematic Review-Gut Permeability as Potential Treatment Target
Sandra J. Van Krimpen et al.
NUTRIENTS (2021)
Association of Obesity With Survival Outcomes in Patients With Cancer A Systematic Review and Meta-analysis
Fausto Petrelli et al.
JAMA NETWORK OPEN (2021)
Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia
Roberta Sartori et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives
Natalia E. Cortez et al.
NUTRIENTS (2021)
Molecular Mechanisms of Skeletal Muscle Hypertrophy
Stefano Schiaffino et al.
JOURNAL OF NEUROMUSCULAR DISEASES (2021)
Sarcopenia as a Predictor of Prognosis in Early Stage Ovarian Cancer
Su Hyun Chae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2021)
Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia
Kristine Pettersen et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
mTORC 1 signalling is not essential for the maintenance of muscle mass and function in adult sedentary mice
Alexander S. Ham et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy
S. Allison Staley et al.
GYNECOLOGIC ONCOLOGY (2020)
Impact of CT-Determined Sarcopenia and Body Composition on Survival Outcome in Patients with Advanced-Stage High-Grade Serous Ovarian Carcinoma
Se Ik Kim et al.
CANCERS (2020)
The Impact of Sarcopenia and Low Muscle Attenuation on Overall Survival in Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis
Veronica McSharry et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer
Chueh-Yi Huang et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis
Emanuele Rinninella et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Management of Cancer Cachexia: ASCO Guideline
Eric J. Roeland et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Control of Adipocyte Thermogenesis and Lipogenesis through β3-Adrenergic and Thyroid Hormone Signal Integration
Adilson Guilherme et al.
CELL REPORTS (2020)
A systematic review and meta-analysis of sarcopenia as a prognostic factor in gynecological malignancy
Emma R. Allanson et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)
Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities consistent with exacerbated cachexia
Joshua R. Huot et al.
JCI INSIGHT (2020)
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Kimberly R. Jordan et al.
CLINICAL CANCER RESEARCH (2020)
No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study
Jorne Ubachs et al.
GYNECOLOGIC ONCOLOGY (2020)
Extreme skeletal muscle loss during induction chemotherapy is an independent predictor of poor survival in advanced epithelial ovarian cancer patients
Yasunori Yoshino et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)
Inflammation and Skeletal Muscle Wasting During Cachexia
Justine M. Webster et al.
FRONTIERS IN PHYSIOLOGY (2020)
Cachexia, a Systemic Disease beyond Muscle Atrophy
Elisabeth Wyart et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Ghrelin-AgRP Neuron Nexus in Anorexia Nervosa: Implications for Metabolic and Behavioral Adaptations
Mathieu Mequinion et al.
FRONTIERS IN NUTRITION (2020)
Liver lipid metabolism disruption in cancer cachexia is aggravated by cla supplementation -induced inflammation
Daniela Caetano Goncalves et al.
CLINICAL NUTRITION (2019)
Adipose tissue dysfunction in cancer cachexia
Sahar I. Daas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism
Fabrizio Pin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review
Markus S. Anker et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism
Huibin Tang et al.
AGING CELL (2019)
Osteoporosis and Sarcopenia Increase Frailty Syndrome in the Elderly
Emanuela A. Greco et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Skeletal muscle atrogenes: From rodent models to human pathologies
Daniel Taillandier et al.
BIOCHIMIE (2019)
Clinical Impact of RANK Signalling in Ovarian Cancer
Verena Wieser et al.
CANCERS (2019)
Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis
Jorne Ubachs et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Molecular Mechanisms Responsible for the Rescue Effects of Pamidronate on Muscle Atrophy in Pediatric Burn Patients
Fabrizio Pin et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Tumor Transcriptome Reveals High Expression of IL-8 in Non-Small Cell Lung Cancer Patients with Low Pectoralis Muscle Area and Reduced Survival
Sarah Santiloni Cury et al.
CANCERS (2019)
Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
Alex R. Straughn et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice
Alyson L. Essex et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy
Chandler S. Callaway et al.
CANCERS (2019)
Sarcopenic Factors May Have No Impact on Outcomes in Ovarian Cancer Patients
Naomi Nakayama et al.
DIAGNOSTICS (2019)
Effect of Estrogen on Musculoskeletal Performance and Injury Risk
Nkechinyere Chidi-Ogbolu et al.
FRONTIERS IN PHYSIOLOGY (2019)
Insulin resistance and body composition in cancer patients
R. Dev et al.
ANNALS OF ONCOLOGY (2018)
Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis
X. Zhang et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2018)
Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning
Jun Han et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Re-evaluating the role of FOXOs in cancer
M. Hornsveld et al.
SEMINARS IN CANCER BIOLOGY (2018)
Increased gut permeability in cancer cachexia: mechanisms and clinical relevance
Laure B. Bindels et al.
Oncotarget (2018)
A randomized trial of adjunct testosterone for cancer-related muscle loss in men and women
Traver J. Wright et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia
Fabrizio Pin et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)
Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery
Beyhan Ataseven et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction
Sarah A. Potgens et al.
SCIENTIFIC REPORTS (2018)
Understanding sex differences in the regulation of cancer-induced muscle wasting
Ryan N. Montalvo et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2018)
Inter-tissue communication in cancer cachexia
Josep M. Argiles et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes
Ya-Chin Hou et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Sarcopenia in Advanced Serous Ovarian Cancer
Holger Bronger et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
TNF-α and cancer cachexia: Molecular insights and clinical implications
Hetal J. Patel et al.
LIFE SCIENCES (2017)
Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease
Justin L. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass
Rafael Barreto et al.
SCIENTIFIC REPORTS (2017)
The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome
Klaske van Norren et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2017)
The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery
I. J. G. Rutten et al.
EJSO (2017)
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response
Shi-Ying Cai et al.
JCI INSIGHT (2017)
MAP3K11/GDF15 axis is a critical driver of cancer cachexia
Lorena Lerner et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis
Selma Masri et al.
CELL (2016)
Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
Thomas R. Flint et al.
CELL METABOLISM (2016)
Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer
Amanika Kumar et al.
GYNECOLOGIC ONCOLOGY (2016)
Cytokine Signaling in Skeletal Muscle Wasting
Jin Zhou et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
Rafael Barreto et al.
ONCOTARGET (2016)
Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
Iris J. G. Rutten et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2016)
Network of hypothalamic neurons that control appetite
Jong-Woo Sohn
BMB REPORTS (2015)
Effect of age on basal muscle protein synthesis and mTORC1 signaling in a large cohort of young and older men and women
Melissa M. Markofski et al.
EXPERIMENTAL GERONTOLOGY (2015)
Role of Activin A and Myostatin in Human Cancer Cachexia
Audrey Loumaye et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity
Shihyin Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Excess TGF-β mediates muscle weakness associated with bone metastases in mice
David L. Waning et al.
NATURE MEDICINE (2015)
The regulation of muscle mass by endogenous glucocorticoids
Theodore P. Braun et al.
FRONTIERS IN PHYSIOLOGY (2015)
Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice
Kara L. Kliewer et al.
CANCER BIOLOGY & THERAPY (2015)
Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
Stefanie Aust et al.
PLOS ONE (2015)
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
J. Aubrey et al.
ACTA PHYSIOLOGICA (2014)
Molecular Mechanisms of Bone Metastasis and Associated Muscle Weakness
David L. Waning et al.
CLINICAL CANCER RESEARCH (2014)
Elevated expression of activins promotes muscle wasting and cachexia
Justin L. Chen et al.
FASEB JOURNAL (2014)
IL-6 Impairs Myogenic Differentiation by Downmodulation of p90RSK/eEF2 and mTOR/p70S6K Axes, without Affecting AKT Activity
Michele Pelosi et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Cancer cachexia: understanding the molecular basis
Josep M. Argiles et al.
NATURE REVIEWS CANCER (2014)
Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK
James P. White et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2013)
The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis
Franck Mauvais-Jarvis et al.
ENDOCRINE REVIEWS (2013)
Nutritional status, CT body composition measures and survival in ovarian cancer
Michelle L. Torres et al.
GYNECOLOGIC ONCOLOGY (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Kenneth C. H. Fearon et al.
CELL METABOLISM (2012)
Glucocorticoids increase interleukin-6-dependent gene induction by interfering with the expression of the suppressor of cytokine signaling 3 feedback inhibitor
Anna Dittrich et al.
HEPATOLOGY (2012)
Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
Miranda Y. Fong et al.
PLOS ONE (2012)
The role of insulin resistance in the development of muscle wasting during cancer cachexia
Mary A. Honors et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2012)
Gut barrier dysfunction in the ApcMin/+ mouse model of colon cancer cachexia
Melissa J. Puppa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Expression Pattern of Receptor Activator of NFκB (RANK) in a Series of Primary Solid Tumors and Related Bone Metastases
Daniele Santini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis
Theodore P. Braun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Definition and classification of cancer cachexia: an international consensus
Kenneth Fearon et al.
LANCET ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
The Regulation of Skeletal Muscle Protein Turnover during the Progression of Cancer Cachexia in the ApcMin/+ Mouse
James P. White et al.
PLOS ONE (2011)
STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
Andrea Bonetto et al.
PLOS ONE (2011)
The advantages and limitations of cross-sectional body composition analysis
Alisdair J. MacDonald et al.
Current Opinion in Supportive and Palliative Care (2011)
Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models
Stefano Schiaffino et al.
SKELETAL MUSCLE (2011)
Benefits of Estrogen Replacement for Skeletal Muscle Mass and Function in Post-Menopausal Females: Evidence from Human and Animal Studies
Peter M. Tiidus
EURASIAN JOURNAL OF MEDICINE (2011)
Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
Xiaolan Zhou et al.
CELL (2010)
Insulin/IGF-1 paradox of aging: Regulation via AKT/IKK/NF-κB signaling
Antero Salminen et al.
CELLULAR SIGNALLING (2010)
Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice
Michelle L. Asp et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The Role of Inflammation in Cholestasis: Clinical and Basic Aspects
Astrid Kosters et al.
SEMINARS IN LIVER DISEASE (2010)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
Interleukin-1 stimulates catabolism in C2C12 myotubes
Wei Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Ovarian cancer: pathology, biology, and disease models
Daniel G. Rosen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy
Valerie Risson et al.
JOURNAL OF CELL BIOLOGY (2009)
Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes Metabolic Changes and Results in Muscle Dystrophy
C. Florian Bentzinger et al.
CELL METABOLISM (2008)
Nuclear factor-kappa B signaling in skeletal muscle atrophy
Hong Li et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
FoxO3 controls autophagy in skeletal muscle in vivo
Cristina Mammucari et al.
CELL METABOLISM (2007)
IGF-1 is downregulated in experimental cancer cachexia
Paola Costelli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues - Association with cytokine expression, insulin resistance, and reduction by pioglitazone
GB Di Gregorio et al.
DIABETES (2005)
IL-6-induced skeletal muscle atrophy
F Haddad et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Cancer cachexia:: the molecular mechanisms
JM Argilés et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2003)
Induction of cachexia in mice by systemically administered myostatin
TA Zimmers et al.
SCIENCE (2002)
Cancer cachexia is mediated in part by the induction of IL-6-like cytokines from the spleen
BE Barton et al.
CYTOKINE (2001)
Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
M Markman et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results
MJ Piccart et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)